CEP 4143
Latest Information Update: 26 Oct 2011
At a glance
- Originator Cephalon
- Class Analgesics; Neuroprotectants
- Mechanism of Action Calpain inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Spinal cord injuries
Most Recent Events
- 26 Mar 2007 Discontinued - Preclinical for Spinal chord injuries in USA (unspecified route)
- 06 Oct 2000 New profile
- 06 Oct 2000 Preclinical development for Neuroprotection/Spinal cord injuries in USA (Unknown route)